Who is sponsoring NCT03456089?

NCT03456089 is sponsored by Christopher Cooper.

What drugs are being tested in NCT03456089?

Interventions in NCT03456089: Urodynamics Testing.

What condition does NCT03456089 study?

NCT03456089 studies Urinary Bladder, Neurogenic, Urodynamics.

Is NCT03456089 still recruiting?

NCT03456089 is currently enrolling by invitation. Last updated 5 December 2024.

Last reviewed 2024-12-05 · How we verify

NCT03456089

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing

ENROLLING BY INVITATION NA Last updated 5 December 2024

What this trial tests

NA trial testing Urodynamics Testing in Urinary Bladder, Neurogenic in 100 participants. Enrolling by invitation.

Timeline

15 April 2018

Primary endpoint
30 December 2025

30 December 2025

Quick facts

Lead sponsor	Christopher Cooper
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	100
Start date	15 April 2018
Primary completion	30 December 2025
Estimated completion	30 December 2025
Sites	1 location across United States

Drugs / interventions tested

Urodynamics Testing

Conditions studied

Urinary Bladder, Neurogenic — all drugs for Urinary Bladder, Neurogenic →
Urodynamics — all drugs for Urodynamics →

Sponsor

Christopher Cooper

Who can join

Adults 1 to 99, any sex, with Urinary Bladder, Neurogenic or Urodynamics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators have developed a novel pressure monitoring device that hooks to standard urinary catheters. The investigators will be testing how the pressure measurements recorded with this device compare to the gold standard measurement of urodynamics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Urinary Bladder, Neurogenic

Currently open trials in the same condition.

NCT06978205 — Effect of Urethral Balloon Dilatation on Urinary Retention After Spinal Cord Injury · NA · recruiting
NCT05141487 — Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder · recruiting
NCT05232253 — Cystoealstometer (Bladder Monitor Device)-Home Use · NA · active not recruiting
NCT04193709 — Recovery of Bladder and Sexual Function After Human Spinal Cord Injury · NA · recruiting
NCT03245242 — Pediatric Urology Recovery After Surgery Endeavor (PURSUE) · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03456089 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Christopher Cooper
Last refreshed: 5 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03456089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing